Islets in Type 2 Diabetes: In Honor of Dr. Robert C. Turner
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
The UK Prospective Diabetes Study (UKPDS) orchestrated by Robert Turner showed that, even with treatment, in type 2 diabetes a progressive β-cell dysfunction in a large number of patients was seen with the eventual need for additional oral antihyperglycemic medication and even insulin treatment (1). Such a progression could be from a continued loss of β-cells, a progressive functional change, or from the combination of both. During the decades when type 2 diabetes was considered mainly a disease of insulin resistance, many older pathology studies that focused on the islets in diabetic pancreata were ignored. However, with the renewed appreciation of the role of the pancreatic β-cell in type 2 diabetes, new studies have focused on what happens to the β-cells in type 2 diabetes. This perspectives in diabetes article will present what we know and still need to know about the islets in type 2 diabetes. ### Islet architecture in human pancreas. The islets of most mammalian species have a nonrandom pattern with a core of β-cells surrounded by a discontinuous mantle of non-β-cells one to three cells thick (2,3). However, islets of human and other primates have a more complex arrangement with many different islet profiles, including cloverleaf patterns. The profile differences have led to controversy about whether they actually have a mantle-core arrangement (3) or were random (4–6). In three dimensions, human islets can be considered as composites of several mantle-core subunits (7) or as lobulated with mantle-core lobules (3). In smaller islets, the rodent mantle core subunit arrangement is maintained, but in larger islets irregular fusion of such subunits are seen (Fig. 1). Most of the non-β-cells are found along penetrations of islet vasculature between subunits and the periphery (3,4), thus maintaining a mantle-core arrangement. Histologically, islets in the type 2 diabetic pancreas do not appear …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“β-Cell mass in T2D likewise varies, overlapping with that of normal individuals ( 55 – 57 ), although current data suggest a 20–60% reduction ( 58 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [56]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Self-citationInclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979 · cited 1×
“It was recently shown that the fibrillar inclusions formed by mutant huntingtin in Huntington’s disease neurons were protective rather than detrimental to the cells in which they occurred (50).”
BackgroundThe unique cytoarchitecture of human pancreatic islets has implications for islet cell function
Cabrera, O., Berman, D. M., Kenyon, N. S., Ricordi, C., Berggren, P.-O., & Caicedo, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510790103 · Cited by 1,312 · cited 1×
“However, in studies using laser-scanning confocal microscopy on fewer islets, the -cell number in islets was estimated to be 55% (2–5 islets/section, 5 pancreata) (5) or 53.”
BackgroundCooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976 · cited 2×
“In pursuit of this clue to the pathogenesis of type 2 diabetes, two independent groups (including Robert Turner’s) reported the amino acid sequence of human IAPP (amylin) in 1987 (28,29), and since then enormous strides have been made in the understanding of the pathogenesis of islet amyloidosis and its potential role…”
BackgroundSelf-citationPancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Lorenzo, A., Razzaboni, B., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820 · cited 3×
“While mature amyloid fibrils were initially thought to be the likely mediators of hIAPP toxicity, it has become increasingly apparent that it is actually the relatively small soluble oligomers of hIAPP that are most toxic to -cells (26,33).”
BackgroundBrissova, M., Fowler, M. J., Nicholson, W. E., Chu, A., Hirshberg, B., Harlan, D. M., & Powers, A. C. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5c6684.2005 · Cited by 797 · cited 1×
“5% (32 islets isolated from 6 pancreata) (6).”
Sakuraba, H., Mizukami, H., Yagihashi, N., Wada, R., Hanyu, C., & Yagihashi, S. (2002) · Diabetologia · doi:10.1007/s125-002-8248-z · Cited by 681 · cited 3×
“(12) found no evidence of apoptosis in either diabetic or nondiabetic individuals.”
BackgroundResultSelective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea
Yoon, K. H., Ko, S. H., Cho, J. H., Lee, J. M., Ahn, Y. B., Song, K. H., Yoo, S. J., Kang, M. I., Cha, B. Y., Lee, K. W., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020735 · Cited by 649 · cited 3×
“(15) showed a linear relation between body weight and -cell mass in a Korean population.”
BackgroundResultSelf-citation
Cited by
Pancreatic islet plasticity: Interspecies comparison of islet architecture and composition
Steiner, D. J., Kim, A., Miller, K., & Hara, M. (2010) · Islets · doi:10.4161/isl.2.3.11815 · Cited by 494
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
Unique Arrangement of α- and β-Cells in Human Islets of Langerhans
Bosco, D., Armanet, M., Morel, P., Niclauss, N., Sgroi, A., Muller, Y. D., Giovannoni, L., Parnaud, G., & Berney, T. (2010) · Diabetes · doi:10.2337/db09-1177 · Cited by 450
“Our description of human islet cell organization is innovative but does not contradict the different views reported so far about the human islet architecture (6,8,9,11,12), including the diametrically opposed opinions describing islets with either segregated or intermingled cell types.”
BackgroundParacrinology of islets and the paracrinopathy of diabetes
Unger, R. H., & Orci, L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006639107 · Cited by 269
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 222
“individuals (55-57), although current data suggest a 20-60% reduction (58).”
BackgroundApoptosis in pancreatic β-islet cells in Type 2 diabetes
Tomita, T. (2016) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2016.919 · Cited by 197
Pancreatic Cancer–Derived Exosomes Cause Paraneoplastic β-cell Dysfunction
Javeed, N., Sagar, G., Dutta, S. K., Smyrk, T. C., Lau, J. S., Bhattacharya, S., Truty, M., Petersen, G. M., Kaufman, R. J., Chari, S. T., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2022 · Cited by 192
Paracrine and autocrine interactions in the human islet: More than meets the eye
Caicedo, A. (2013) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.09.007 · Cited by 175
Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits
Spijker, H. S., Song, H., Ellenbroek, J. H., Roefs, M. M., Engelse, M. A., Bos, E., Koster, A. J., Rabelink, T. J., Hansen, B. C., Clark, A., et al. (2015) · Diabetes · doi:10.2337/db14-1752 · Cited by 172
Clinical and Experimental Pancreatic Islet Transplantation to Striated Muscle
Christoffersson, G., Henriksnäs, J., Johansson, L., Rolny, C., Ahlström, H., Caballero-Corbalan, J., Segersvärd, R., Permert, J., Korsgren, O., Carlsson, P.-O., et al. (2010) · Diabetes · doi:10.2337/db10-0205 · Cited by 167
Mohapatra, S., Majumder, S., Smyrk, T. C., Zhang, L., Matveyenko, A. V., Kudva, Y. C., & Chari, S. T. (2016) · Pancreas · doi:10.1097/mpa.0000000000000609 · Cited by 141
Cell–cell interactions in the endocrine pancreas
Jain, R., & Lammert, E. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01102.x · Cited by 145
Hellman, B., Salehi, A., Gylfe, E., Dansk, H., & Grapengiesser, E. (2009) · Endocrinology · doi:10.1210/en.2009-0600 · Cited by 115
Thivolet, C. H., Vial, G., Cassel, R., Rieusset, J., & Madec, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182027 · Cited by 105
Genetic risk converges on regulatory networks mediating early type 2 diabetes
Walker, J. T., Saunders, D. C., Rai, V., Chen, H., Orchard, P., Dai, C., Pettway, Y. D., Hopkirk, A. L., Reihsmann, C., Tao, Y., et al. (2023) · Nature · doi:10.1038/s41586-023-06693-2 · Cited by 93
“Donor-to-donor variability in β and α cell ratio was notable, underscoring the challenge in working with heterogeneous human tissues 113 , but no differences were detected between groups in this cohort 30,114–116 .”
The Human Islet: Mini-Organ With Mega-Impact
Walker, J. T., Saunders, D. C., Briššová, M., & Powers, A. C. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab010 · Cited by 97
Glucolipotoxicity and beta cells in type 2 diabetes mellitus: Target for durable therapy?
van Raalte, D. H., & Diamant, M. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70012-2 · Cited by 99
Yadav, R., Dey, D. K., Vij, R., Meena, S., Kapila, R., & Kapila, S. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.10.015 · Cited by 73
Schmidt, S., Jakab, M., Jav, S., Streif, D., Pitschmann, A., Zehl, M., Purevsuren, S., Glasl, S., & Ritter, M. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.08.013 · Cited by 74
A Conserved Rule for Pancreatic Islet Organization
Hoang, D.-T., Matsunari, H., Nagaya, M., Nagashima, H., Millis, J. M., Witkowski, P., Periwal, V., Hara, M., & Jo, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110384 · Cited by 64
Mohammed, A., Koorbanally, N. A., & Islam, M. S. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.01.009 · Cited by 61
Levetan, C. S., & Pierce, S. M. (2012) · Endocrine Practice · doi:10.4158/ep12138.ra · Cited by 60
Meng, F., Abedini, A., Plesner, A., Middleton, C. T., Potter, K. J., Zanni, M. T., Verchere, C. B., & Raleigh, D. P. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.001 · Cited by 53
Insulitis in human diabetes: a histological evaluation of donor pancreases
Lundberg, M., Seiron, P., Ingvast, S., Korsgren, O., & Skog, O. (2016) · Diabetologia · doi:10.1007/s00125-016-4140-z · Cited by 51
Effect of lemongrass (Cymbopogon citratus Stapf) tea in a type 2 diabetes rat model
Garba, H. A., Mohammed, A., Ibrahim, M. A., & Shuaibu, M. N. (2020) · Clinical Phytoscience · doi:10.1186/s40816-020-00167-y · Cited by 48
“Studies have shown that chronic uncontrolled T2D may led to reduction of circulating insulin levels, and alter the pancreatic integrity and function [38, 39], which were observed in our present study.”
BackgroundGuardado Mendoza, R., Perego, C., Finzi, G., La Rosa, S., Capella, C., Jimenez-Ceja, L. M., Velloso, L. A., Saad, M. J. A., Sessa, F., Bertuzzi, F., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3625-5 · Cited by 41
Cell rearrangement in transplanted human islets
Lavallard, V., Armanet, M., Parnaud, G., Meyer, J., Barbieux, C., Montanari, E., Meier, R. P. H., Morel, P., Berney, T., & Bosco, D. (2015) · The FASEB Journal · doi:10.1096/fj.15-273805 · Cited by 33
Striegel, D. A., Hara, M., & Periwal, V. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004423 · Cited by 31
“The functional characteristics of the sub-unit structures that Bonner-Weir and co-workers have suggested in islets [24] may provide a clue as to why β-cell migration may proceed from larger clusters to smaller.”
BackgroundInfluentialMolecular Pathways Underlying the Pathogenesis of Pancreatic α-Cell Dysfunction
Kawamori, D., Welters, H. J., & Kulkarni, R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_18 · Cited by 27
Growth factor signalling in the regulation of α ‐cell fate
Kawamori, D., Akiyama, M., Hu, J., Hambro, B., & Kulkarni, R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01442.x · Cited by 27
Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects
Tomita, T. (2012) · Islets · doi:10.4161/isl.20477 · Cited by 25
Bruton’s Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in Rats
Erickson, R. I., Schutt, L., Tarrant, J. M., McDowell, M., Liu, L., Johnson, A. R., Lewin-Koh, S.-C., Hedehus, M., Ross, J., Carano, R. A. D., et al. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.236224 · Cited by 24
“…beta-cell mass, amyloid deposition, and inflammation; notably, however, hemorrhage has not been reported as a feature characterizing the pancreatic pathology (Junger et al., 2002; Hull et al., 2005; Iizuka et al., 2005; Bonner-Weir and O’Brien, 2008; Donath et al., 2008; Talchai et al., 2009).”
BackgroundAccumulation of Intrahepatic Islet Amyloid in a Nonhuman Primate Transplant Model
Liu, C., Koeberlein, B., Feldman, M. D., Mueller, R., Wang, Z., Li, Y., Lane, K., Hoyt, C. C., Tomaszewski, J. E., Naji, A., et al. (2012) · Endocrinology · doi:10.1210/en.2011-1560 · Cited by 25
Santos-Silva, J. C., Carvalho, C. P. D. F., de Oliveira, R. B., Boschero, A. C., & Collares‐Buzato, C. B. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-064 · Cited by 25
Meng, F., & Raleigh, D. P. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.12.028 · Cited by 21
“IAPP is stored in the pancreatic β-cells in the same secretory granules as insulin, processed in parallel with insulin and secreted in response to the same stimuli.(8,15,16,21,22) IAPP is produced as an 89-residue preprohormone, pre-pro-islet amyloid polypeptide (proIAPP).”
BackgroundHenson, M. S., Hegstad‐Davies, R. L., Wang, Q., Hardy, R. M., Armstrong, P., Jordan, K., Johnson, K. H., & O’Brien, T. D. (2011) · American Journal of Veterinary Research · doi:10.2460/ajvr.72.8.1052 · Cited by 19
Self-citationMaternal N-Acetyl Cysteine Intake Improved Glucose Tolerance in Obese Mice Offspring
Michlin, M., Argaev-Frenkel, L., Weinstein‐Fudim, L., Ornoy, A., & Rosenzweig, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061981 · Cited by 13
Thole, A. A., Rodrigues-Cunha, A. C. D. S., de Carvalho, S. N., Garcia‐Souza, É. P., Cortez, E. A. C., Stumbo, A. C., de Carvalho, L., & Moura, A. S. (2012) · Tissue and Cell · doi:10.1016/j.tice.2012.04.001 · Cited by 14
PROLEGOMENON TO THE EUROPEAN CONSTITUTION BOOK OF DIABETES MELLITUS
Ionescu-Tirgoviste, C., & Paulescu, N. (2008) · Cited by 13
Clair, J. R. S., Westacott, M. J., Miranda, J., Farnsworth, N. L., Kravets, V. V., Schleicher, W. E., Dwulet, J. M., Levitt, C. H., Heintz, A., Ludin, N. W. F., et al. (2023) · The Journal of Physiology · doi:10.1113/jp282114 · Cited by 13
Colegrove, K. M., & Venn-Watson, S. K. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.02.023 · Cited by 10
Cheng, Y., Shen, J., Ren, W., Hao, H., Xie, Z., Liu, J., Mu, Y., & Han, W. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12540 · Cited by 10
Liu, X., Ruan, J., Xia, J., Yang, S., Fan, J., & Li, K. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2081-8 · Cited by 8
“addition, oxidative stress would affect hIAPP aggregation in the cells [26, 27].”
BackgroundIftikhar, A., Nausheen, R., Khurshid, M., Iqbal, R. K., Muzaffar, H., Malik, A., Khan, A. A., Batool, F., Akhtar, S., Yasin, A., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20017 · Cited by 7
“On the other hand, type 2 diabetes mellitus is linked to metabolic syndrome and insulin insensitivity; islet amyloid presents the typical histological finding in islet cells of patients with this form of diabetes [4].”
BackgroundAdaptation of pancreatic islet cyto-architecture during development
Striegel, D. A., Hara, M., & Periwal, V. (2016) · Physical Biology · doi:10.1088/1478-3975/13/2/025004 · Cited by 7
Pfeifer, M. A., Langehein, H., Grupe, K., Müller, S., Seyda, J., Liebmann, M., Rustenbeck, I., & Scherneck, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1250023 · Cited by 6
Khalifa, J., Bourgault, S., & Gaudreault, R. (2023) · Current Alzheimer Research · doi:10.2174/0115672050277001231213073043 · Cited by 7
Mkolo, N. M., Olaokun, O. O., King, P. H., van Rensburg, I. J., Eloff, J. N., & Naidoo, V. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03640-y · Cited by 5
Growth Factor Mediated Regulation of Beta Cell Survival
Vasavada, R. C. (2010) · The Open Endocrinology Journal · doi:10.2174/1874216501004010078 · Cited by 6
Wedgwood, K. C. A., & Satin, L. S. (2018) · Physics of Life Reviews · doi:10.1016/j.plrev.2018.01.005 · Cited by 4
“Gosak et al (2018) use networks of insulin-secreting beta cells within pancreatic islets, whose dysfunction is implicated in type 2 diabetes (Bonner-Weir and O’Brien, 2008), as an example for network analysis.”
Srisutha, J., Watari, I., Akakura, M., Watanabe, M., Changsiripun, C., & Ono, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-60519-3 · Cited by 4
Lundberg, M., Stenwall, A., Tegehall, A., Korsgren, O., & Skog, O. (2018) · Islets · doi:10.1080/19382014.2018.1433980 · Cited by 4
Floros, X., Fuchs, T. J., Rechsteiner, M., Spinas, G. A., Moch, H., & Buhmann, J. M. (2009) · Lecture notes in computer science · doi:10.1007/978-3-642-04271-3_77 · Cited by 4
Regulation of Insulin Secretion and Islet Cell Function
Weir, G. C., Bonner‐Weir, S., & Sharma, A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1028-7_1 · Cited by 4
Self-citationGlucagón: ¿un simple espectador o un jugador clave en la fisiopatología de la diabetes?
Lima-Martínez, M. M., Betancourt, L. R., & Bermúdez, A. (2011) · Avances en Diabetología · doi:10.1016/j.avdiab.2011.09.002 · Cited by 6
Apoptosis in Pancreatic β-Islet Cells in Type 1 and Type 2 Diabetes
Tomita, T. (2013) · Springer eBooks · doi:10.1007/978-94-007-6884-0_45-1 · Cited by 1
Molecular Mechanism Underlying the Intra-Islet Regulation of Glucagon Secretion
Kawamori, D., & Rohit, N. K. (2011) · InTech eBooks · doi:10.5772/24792 · Cited by 1
“…2) human islets consist of several clover-leaf like ‘rosettes’, with each rosette resembling the basic islet architecture observed in rodent islets (Bonner-Weir and O'Brien, 2008) suggesting Schematic image for the structure of mouse and human islets adapted from the recent publication of…”
BackgroundDietary Proanthocyanidin Modulation of Pancreatic β Cells
Pinent, M., González‐Abuín, N., Blay, M., & Ardèvol, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00016-6 · Cited by 3
Architecture and Morphology of Human Pancreatic Islets
Powers, A. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408134-5.00016-0 · Cited by 2
Mathematical Modeling of Islet Generation, Degeneration and Regeneration
Jo, J., Striegel, D. A., Hara, M., & Periwal, V. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-45307-1_3 · Cited by 1
Heimann, E. (2014) · Lund University Publications (Lund University)
4. New Insights of Islet Biology and the Pathophysiology of Type 2 Diabetes
Powers, A. C., & Stein, R. W. (2011) · Translational endocrinology & metabolism · doi:10.1210/team.9781879225824.ch4 · Cited by 2
Epigenetic Regulation of the Dlk1-Meg3 Imprinted Locus in Human Islets
Kameswaran, V. (2016) · ScholarlyCommons (University of Pennsylvania)
Apoptosis in Pancreatic β-Cells in Type 1 and Type 2 Diabetes
Tomita, T. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_45
Apoptosis in Pancreatic b-Cells in Type 1 and Type 2 Diabetes 31
Tomita, T. (2015)
Effects and underlying mechanism of plant secondary metabolites on insulin secretion regulation
Patyra, A. (2023) · theses.fr (ABES) · doi:10.70675/f6232418z15acz4262z8817z3f3a0aa0263d
Mkolo, N. M., Olaokun, O. O., King, P. H., Janse van Rensburg, I., Eloff, J. N., & Naidoo, V. (2022) · Figshare · doi:10.6084/m9.figshare.20110497
Metadata
- Authors
- Bonner-Weir, S., & O'Brien, T. D.
- Affiliations
- Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts
- Department of Veterinary Population Medicine and Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-11-01
- Volume
- 57
- Issue
- 11
- Pages
- 2899-2904
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2570382
- OpenAlex
- W2170188899
- Cited by
- 66
- References
- 52
- Citations by year
- 2024: 1 · 2023: 5 · 2022: 2 · 2021: 1 · 2020: 2 · 2018: 3 · 2017: 1 · 2016: 9 · 2015: 6 · 2014: 8 · 2013: 2 · 2012: 6
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 2 diabetes, pancreatic islets, beta-cell dysfunction, islet architecture, beta cell destruction, insulin resistance, UK Prospective Diabetes Study
- MeSH terms
- Amyloid, Amyloidosis, Diabetes Mellitus, Type 2, Humans, Islets of Langerhans, Biomedical Research, History, 20th Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.